ID26861A - Terapi gabungan untuk pengobatan depresi refaktori - Google Patents

Terapi gabungan untuk pengobatan depresi refaktori

Info

Publication number
ID26861A
ID26861A IDW20002339A ID20002339A ID26861A ID 26861 A ID26861 A ID 26861A ID W20002339 A IDW20002339 A ID W20002339A ID 20002339 A ID20002339 A ID 20002339A ID 26861 A ID26861 A ID 26861A
Authority
ID
Indonesia
Prior art keywords
refactors
join
depression
therapy
treatment
Prior art date
Application number
IDW20002339A
Other languages
English (en)
Indonesian (id)
Inventor
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID26861A publication Critical patent/ID26861A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Oxide Ceramics (AREA)
IDW20002339A 1998-05-22 1999-05-21 Terapi gabungan untuk pengobatan depresi refaktori ID26861A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8644498P 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
ID26861A true ID26861A (id) 2001-02-15

Family

ID=22198612

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002339A ID26861A (id) 1998-05-22 1999-05-21 Terapi gabungan untuk pengobatan depresi refaktori

Country Status (24)

Country Link
EP (1) EP0958824A3 (fr)
JP (1) JP2002516282A (fr)
KR (1) KR20010043730A (fr)
CN (1) CN1154496C (fr)
AU (1) AU761510B2 (fr)
BR (1) BR9911049A (fr)
CA (1) CA2332814C (fr)
CZ (1) CZ20004279A3 (fr)
EA (1) EA004539B1 (fr)
HK (1) HK1040055B (fr)
HR (1) HRP20000797A2 (fr)
HU (1) HUP0101901A3 (fr)
ID (1) ID26861A (fr)
IL (1) IL139592A (fr)
MY (1) MY127938A (fr)
NO (1) NO20005885L (fr)
NZ (1) NZ507980A (fr)
PL (1) PL344331A1 (fr)
SK (1) SK17512000A3 (fr)
TR (1) TR200003443T2 (fr)
TW (1) TWI226829B (fr)
UA (1) UA78181C2 (fr)
WO (1) WO1999061027A1 (fr)
ZA (1) ZA200006815B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1133299A1 (fr) * 1998-11-23 2001-09-19 Sepracor Inc. Compositions a base de 2-hydroxymethylolanzapine et leurs utilisations
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
EP1782813A1 (fr) * 1999-12-06 2007-05-09 H.Lundbeck A/S Combinaison d'un inhibiteur du recaptage de la serotonine et d'un antagoniste, d'un agoniste inverse ou d'un agoniste partiel de 5-ht
EP1353675A2 (fr) * 2001-01-02 2003-10-22 PHARMACIA & UPJOHN COMPANY Nouvelles combinaisons medicamenteuses
EP1551393A4 (fr) 2002-07-30 2010-06-16 Peter Migaly Combinaison de therapie pour la depression, la prevention du suicide et divers troubles medicaux et psychiatriques
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
RU2356554C2 (ru) 2002-12-27 2009-05-27 Оцука Фармасьютикал Ко., Лтд. Производные карбостирила и ингибиторы обратного захвата серотонина для лечения эмоциональных расстройств
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
MXPA06002504A (es) * 2003-09-04 2006-06-20 Lundbeck & Co As H Combinacion de un inhibidor de recaptacion de serotonina y loxapina.
MXPA06003150A (es) 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
EP1713486A4 (fr) * 2003-12-02 2009-04-29 Sheldon Leslie James Therapie combinee pour le traitement de la demence, la depression et l'apathie
WO2005056056A2 (fr) * 2003-12-15 2005-06-23 H. Lundbeck A/S Combinaison d'un inhibiteur de reabsorption de la serotonine et d'un antagoniste du recepteur de l'histamine 3, agoniste inverse ou partiel
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
JP2009506069A (ja) * 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
KR20090028712A (ko) 2006-06-16 2009-03-19 하. 룬트벡 아크티에 셀스카브 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ｈｔ3 및 5-ｈｔ1ａ 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진
CA2677623C (fr) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd Forme pharmaceutique contenant deux ou davantage de principes actifs pharmaceutiques sous des formes physiques differentes
TWI432194B (zh) * 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CN105769875A (zh) * 2014-12-22 2016-07-20 扬子江药业集团上海海尼药业有限公司 复方奥氮平盐酸氟西汀胶囊的制备方法
CN108938645A (zh) * 2018-08-24 2018-12-07 山西医科大学第医院 一种抗精神病药物组合物
CN111084778B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种奥氮平盐酸氟西汀胶囊及其制备方法
CN114569566A (zh) * 2020-12-02 2022-06-03 四川科瑞德制药股份有限公司 一种盐酸米那普仑制剂的制备方法
ES3054324A1 (es) * 2024-07-12 2026-02-02 Univ Malaga Galanina (1-15) y Fluoxetina en el tratamiento de la depresión resistente al tratamiento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0889725A4 (fr) * 1996-03-11 2000-01-19 Lilly Co Eli Methode de traitement des troubles bipolaires
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
NO20005885D0 (no) 2000-11-21
HUP0101901A3 (en) 2002-06-28
JP2002516282A (ja) 2002-06-04
HK1040055B (zh) 2005-04-01
CA2332814A1 (fr) 1999-12-02
KR20010043730A (ko) 2001-05-25
CZ20004279A3 (cs) 2001-09-12
HK1040055A1 (en) 2002-05-24
CN1311681A (zh) 2001-09-05
TWI226829B (en) 2005-01-21
MY127938A (en) 2007-01-31
BR9911049A (pt) 2001-02-06
EP0958824A3 (fr) 1999-12-01
UA78181C2 (en) 2007-03-15
IL139592A (en) 2005-08-31
NZ507980A (en) 2003-10-31
TR200003443T2 (tr) 2001-03-21
HUP0101901A2 (hu) 2001-11-28
EP0958824A2 (fr) 1999-11-24
AU4008699A (en) 1999-12-13
SK17512000A3 (sk) 2002-02-05
PL344331A1 (en) 2001-11-05
EA004539B1 (ru) 2004-06-24
HRP20000797A2 (en) 2001-10-31
NO20005885L (no) 2001-01-17
CN1154496C (zh) 2004-06-23
IL139592A0 (en) 2002-02-10
WO1999061027A1 (fr) 1999-12-02
EA200001218A1 (ru) 2001-06-25
CA2332814C (fr) 2008-11-04
ZA200006815B (en) 2002-01-14
AU761510B2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
ID24118A (id) Terapi gabungan
ID27841A (id) Turunan-turunan biaril terapeutik
ID25921A (id) Sulfonamida-sulfonamida untuk pengobatan penyakit-penyakit yang dimediakan endotelin
ID22878A (id) Komposisi aktif secara terapi
FI20000863A0 (fi) Uusi hoitomenetelmä
EP1077704A4 (fr) Therapie combinee destinee au traitement de la depression
ID27191A (id) Metode untuk pengobatan insomnia
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ID18679A (id) Penggunaan terapi lanjutan
EP0996433A4 (fr) Procedes de traitement d'etats associes au lactosylceramide
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO20005179D0 (no) Medikament behandling
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID27483A (id) Metoda terapi gen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
ID24922A (id) Terapi kombinasi untuk pengobatan aids
NO20006383D0 (no) Fremgangsmåte for behandling
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID29414A (id) Pengobatan depresi
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO20012301D0 (no) Ny fremgangsmåte for behandling
ID17459A (id) Unsur-unsur pengobatan
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки